Vfend Powder, For Suspension
Product Images NDC 0049-3160

20 FDA label images from Roerig · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Vfend (NDC 0049-3160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vfend 01)

Chemical Structure (Vfend 01)
Chemical structure of the active ingredient in VFEND, showing the molecular arrangement including fluorinated aromatic rings, a hydroxyl group, and a methyl substitution.*
FDA Label Image

Logo (Vfend 02)

FDA Label Image

Logo (Vfend 03)

FDA Label Image

Image (Vfend 04)

Image (Vfend 04)
An instructional diagram showing components of the VFEND oral liquid medication dispenser system. Labeled parts include the Child-Resistant Bottle Cap, Bottle, Bottle Adapter, Plunger, Oral Dispenser, and Tip. The illustration clarifies how these parts fit together for medication administration.*
FDA Label Image

Image (Vfend 05)

Image (Vfend 05)
An instructional illustration showing a person using both hands to grip a bottle with a child-resistant cap. One hand is holding the bottle while the other is pushing down and turning the cap, demonstrating how to open it.*
FDA Label Image

Image (Vfend 06)

Image (Vfend 06)
An instructional illustration showing hands opening or closing a bottle by pressing down and turning the cap, indicated by downward arrows. The image is likely related to safe handling or administration instructions for VFEND, but contains no text or product details.*
FDA Label Image

Image (Vfend 07)

Image (Vfend 07)
A grayscale image showing the top portion of a cylindrical bottle with an open threaded neck designed for a screw cap closure. The bottle is empty and has no visible label or markings. No other product-specific information is visible in the image.*
FDA Label Image

Image (Vfend 08)

Image (Vfend 08)
An instructional illustration showing a hand holding a syringe while pushing the plunger downward. A dark arrow indicates the direction of movement for the plunger. The image likely demonstrates the correct technique for administering or preparing a dose using a syringe, relevant to VFEND products.*
FDA Label Image

Image (Vfend 09)

Image (Vfend 09)
An instructional illustration showing a hand using a syringe to draw liquid from a bottle. The syringe is inserted into the bottle through the cap, demonstrating a step of medication preparation or dosing.*
FDA Label Image

Image (Vfend 10)

Image (Vfend 10)
An instructional line drawing showing a hand holding a vial and a syringe. The syringe is being inserted into the vial, illustrating the process of drawing liquid medication from the vial into the syringe. No text or brand information is visible.*
FDA Label Image

Image (Vfend 11)

Image (Vfend 11)
An instructional diagram showing a person holding a vial upside down and withdrawing liquid into a syringe. The image demonstrates the proper technique to draw medication from a vial using a syringe with one hand stabilizing the vial and the other hand pulling the syringe plunger down.*
FDA Label Image

Image (Vfend 12)

Image (Vfend 12)
An instructional line drawing showing a hand holding a syringe that is being inserted into the stopper of a vial. The illustration likely represents medication preparation by drawing liquid from the vial into the syringe.*
FDA Label Image

Image (Vfend 13)

Image (Vfend 13)
An instructional illustration showing a person opening a screw-cap bottle by twisting the cap counterclockwise. The image depicts both hands holding and manipulating the bottle and cap, indicating the proper method to open the container.*
FDA Label Image

Logo (Vfend 14)

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
Label for Vfend (voriconazole) 50 mg tablets by Roerig, a division of Pfizer Inc. The label includes storage instructions (15°C to 30°C), dosage directions to see prescribing information, and states each tablet contains 50 mg voriconazole. The package contains 30 tablets and is marked Rx only. The product is made in Ireland.*
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
VFEND 200 mg tablets label showing voriconazole as the active ingredient. The label indicates a package count of 30 tablets, distributed by Roerig, a division of Pfizer Inc. Storage instructions specify controlled room temperature between 15°C to 30°C. The label includes dosage guidance to refer to prescribing information.*
FDA Label Image

Principal Display Panel (200 mg Vial Label)

Principal Display Panel (200 mg Vial Label)
VFEND I.V. 200 mg vial label for voriconazole injection by Roerig, a division of Pfizer. The label indicates the product strength as 200 mg of voriconazole per vial, for intravenous infusion only. It states the vial is sterile, single-dose with no preservatives and is not made with natural rubber latex. The label includes storage instructions and dispensing information.*
FDA Label Image

Principal Display Panel (200 mg Vial Carton)

Principal Display Panel (200 mg Vial Carton)
Packaging label for Vfend I.V. 200 mg (voriconazole) sterile single-dose vial for injection. The label states it is for intravenous infusion only, not made with natural rubber latex, and contains no preservatives. Distributed by Roerig, a division of Pfizer Inc. The label includes dosage preparation instructions and storage information.*
FDA Label Image

Principal Display Panel (40 mg Bottle Label)

Principal Display Panel (40 mg Bottle Label)
Label for Vfend oral suspension containing voriconazole 40 mg/mL, 75 mL bottle when reconstituted. The product is orange flavored and distributed by Roerig, a division of Pfizer Inc. Instructions specify refrigeration of dry powder before reconstitution and storage of suspension at controlled room temperature.*
FDA Label Image

Principal Display Panel (40 mg Bottle Carton)

Principal Display Panel (40 mg Bottle Carton)
Packaging label for Vfend oral suspension 40 mg/mL (voriconazole), distributed by Roerig, division of Pfizer Inc. The label indicates an orange-flavored oral suspension with a 75 mL volume when reconstituted. It includes dosing instructions, storage conditions, and cautions such as shaking before use and discarding unused suspension after 14 days. The label features the Pfizer logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.